M
any Americans survive a heart attack only to die soon after leaving the hospital from a second heart attack or other medical problem. But a new study sponsored by the Agency for Healthcare Research and Quality suggests that heart attack patients fare better if they are treated by a cardiologist and better still if they are treated by a cardiologist and a family physician or internist rather than by a primary care physician alone after they go home from the hospital.
The researchers found that patients cared for by cardiologists on an outpatient basis following a heart attack have a lower risk of dying within 2 years than patients seen only by primary care physicians (14.6 percent vs. 18.3 percent). Also, patients cared for by both a cardiologist and a primary care physician have an even lower risk of dying within 2 years than those treated solely by a cardiologist (11.1 percent vs. 12.1 percent). In these two comparisons, patients in each group were similar in age, sex, race, and clinical characteristics, and those in the first comparison were relatively sicker with a higher risk of dying.
According to Harvard Medical School researcher John Ayanian, M.D., who led the study, the tests and procedures that cardiologists can provide their patients-such as exercise testing, angiograms, heart bypass surgery, and cardiac rehabilitation-together with the experience that primary care physicians have in managing common chronic illnesses, may explain the success of this combination.
However, the researchers did not find that the cardiologists' patients used effective cardiac drugs to any significantly greater extent than other patients. In fact, regardless of which type of physician the heart attack survivors used for followup care, many were not prescribed drugs that have been proven effective, such as beta-blockers and cholesterol-lowering medications. On the other hand, the cardiologists' patients were more likely to undergo major diagnostic and treatment procedures such as angiograms and heart bypass
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Researchers examine the risk factors for sudden cardiac death and management of at-risk patients Heart attack continued from page 1 surgery, which may have contributed to their better outcomes. The study also found that the patients who were less likely to see a cardiologist for followup care were those who had major chronic illnesses such as congestive heart failure, diabetes, or lung disease, and those who were black, female, or very elderly. Patients who underwent major cardiac procedures while hospitalized, such as heart bypass surgery, were more likely to receive followup from a cardiologist after leaving the hospital.
The researchers examined 1994 and 1995 data on the medical care of more than 35,000 elderly heart attack survivors for 3 months after hospital discharge-the normal timeframe for such patients to begin seeing physicians for SCDs, and 442 randomly selected control patients. Patients who died during followup, either suddenly or nonsuddenly, differed in numerous ways from the randomly selected control patients. For example, patients who died were significantly older, more likely to have had a prior heart attack or congestive heart failure, more likely to have diabetes, and less likely to have been discharged on beta-blockers or aspirin.
Yet very few factors distinguished patients with subsequent SCD from those who died not suddenly. Cardiac test results and discharge medications of patients who died suddenly were quite similar to those of patients who died nonsuddenly. Women, patients who had angioplasty or bypass surgery, and patients prescribed beta-blockers were 20 to 30 percent less likely to die suddenly than other patients. Those with heart failure, frequent ventricular ectopy, or a discharge diagnosis of heart attack were 20 to 30 percent more likely to die suddenly than other patients. However, a model containing all clinical variables had only a modest ability to predict mode of death. By preventing or terminating ventricular arrhythmias (irregular heart beats) in patients who have already suffered a heart attack, the type III antiarrhythmic agent amiodarone and the ICD substantially reduce SCD, according to this study. The investigators reviewed randomized trials and quantitative overviews of type I and type III antiarrhythmic drugs and randomized trials of ICDs and combined these outcomes in a quantitative overview. The Cardiac Arrhythmia Suppression Trial (CAST) and meta-analyses of other studies suggested that type I agents increased by 21 percent the mortality rate of heart attack patients who had no symptoms of irregular heart beat but were at risk of sudden death.
Heidenreich
Randomized trials of amiodarone suggested a moderate 13 to 19 percent decrease in mortality rate relative to placebo, and sotalol, another type III agent, was effective in several small trials. Trials of pure type III agents, however, showed no reduced mortality.
An overview of ICD trials revealed a 24 percent reduction in mortality rate compared with amiodarone. The benefit of the device was greater in patients with an ejection fraction (a measure of cardiac output) of 35 percent or less. The evidence supporting the efficacy of the ICD was strongest in patients who had experienced an episode of sustained ventricular tachycardia (abnormally rapid heart beat) or ventricular fibrillation (irregular heart beat).
The researchers suggest that type I agents be reserved for patients with symptomatic atrial arrhythmias and, even in these patients, other therapies may be preferred when the ejection fraction is substantially reduced. They conclude that amiodarone remains an acceptable therapeutic option, particularly as preventive therapy, in patients at high risk of SCD who have not experienced an episode of sustained ventricular tachycardia or fibrillation. The ICD is effective in patients with prior episodes of sustained ventricular tachycardia or fibrillation. Note: Only items marked with a single (*) or double (**) asterisk are available from AHRQ. Items marked with a single asterisk (*) are available from AHRQ's clearinghouse. Items with a double asterisk (**) are also available through AHRQ InstantFAX. Three asterisks (***) indicate NTIS availability. See the back cover of Research Activities for ordering information. Consult a reference librarian for information on obtaining copies of articles not marked with an asterisk.
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continued from page 3 providing better methods to detect and treat sustained ventricular tachyarrhythmias (rapid, irregular heart beat). This study found that ICD use expanded more than 10-fold in clinical practice from 1987 to 1995, with improved mortality rates but high medical expenditures and rates of surgical revision. The investigators identified ICD recipients by use of the hospital discharge databases of Medicare beneficiaries for 1987 through 1995 and of California residents for 1991 through 1995. They linked the initial hospital admission for each ICD patient to previous and subsequent admissions and to mortality files to determine the outcomes of ICD use.
During the study period, over 31,000 ICDs were implanted in Medicare patients, most of whom had been hospitalized for heart attack, congestive heart failure, or ventricular tachycardia at that time or during the previous year. Between 1987 and 1995, the number of hospitals performing the procedure increased from roughly 100 to 500, and the volume of ICD implantations per hospital also rose. Patients who died within 30 days of implantation decreased from 6 to 2 percent, and mortality rates within a year of implantation fell from 19 to 11 percent. Mortality rates at 3 years declined as well, but less sharply, from 38 percent in 1987 to 33 percent in 1992.
Subsequent hospitalizations for ICD complications or surgical replacement were very common and within the first year remained about 5 percent. However, the rate of revision/replacement at 3 years declined from 34 percent from 1987 to 1989 to 18 percent for devices implanted from 1990 to 1992, largely as a result of fewer generator replacements due to improvements in device and battery life. Medicare expenditures for these patients within 30 days of ICD implantation have remained close to $40,000 in 1993 dollars, and 3-year expenditures averaged almost $50,000. Clinical trials tend to assess one treatment at a time, yet most patients are treated with multiple therapies simultaneously, and interactions are often unpredictable. Assumptions by clinicians about untested combinations of potent therapies may not only be incorrect, but they also could lead to widespread patient problems. Long-term effects of therapies may differ from short-term effects and deserve evaluation.
McDonald
The effect of drugs in the same class (that is, with the same biological target) can be uncertain. For example, in the treatment of heart failure, three beta-blockers reduced mortality, but a fourth failed in a major trial. Clinicians should consider uncertainty when substituting a less-expensive but unproven agent from the same class for a given condition. Referring high-risk surgeries to high-volume hospitals may save lives but not money T he well-publicized decline in postoperative deaths following cardiovascular surgery has led to a general perception that high-risk surgery is becoming safer over time. However, that is not the case for high-risk cancer operations, concludes a study supported in part by the Agency for Healthcare Research and Quality (HS10141). Organized efforts aimed at measuring surgical mortality rates-like those widely implemented in cardiac surgery-may be the first step toward making high-risk cancer surgery safer, suggests principal investigator John D. Birkmeyer, M.D., of Dartmouth-Hitchcock Medical Center.
Dr. Birkmeyer and colleagues examined national trends between 1994 and 1999 in operative mortality for 14 high-risk cardiovascular and cancer procedures in a nationally representative group of elderly Medicare patients. Mortality rates varied widely across the 14 procedures, from 2 percent for carotid endarterectomy (removal of plaque from the carotid artery) to 16 percent for esophagectomy (removal of all or part of the esophagus). Over the 6-year study period, operative mortality declined significantly for three cardiovascular procedures: 15 percent for coronary artery bypass graft (CABG) surgery, 14 percent for carotid endarterectomy, and 11 percent for mitral valve replacement.
On the other hand, operative mortality did not decline significantly for seven of eight cancer procedures studied. In fact, mortality increased for colonectomy for colon cancer, after adjusting for other factors known to affect operative mortality, such as hospital procedure volume. Mortality rates remained higher than 10 percent throughout the study period for cancer surgeries such as pneumonectomy (removal of all or part of a lung), gastrectomy (removal of all or part of the stomach), and pancreatic resection and remained at least 15 percent for esophagectomy.
Registries tracking hospital-and surgeon-specific performance have been linked to substantial reductions in operative mortality with cardiac surgery. Although there are several large cancer registries, these tend to focus on disease epidemiology and prognosis. If expanded to allow tracking of provider-level performance, these registries might be very useful as platforms for improving surgical outcomes.
See "Is surgery getting safer? National trends in operative mortality," by Philip P. (5), pp. 234-241. ■ I n 1980, endometrial ablation was introduced as an alternative to hysterectomy for abnormal uterine bleeding. Its aim is to alleviate excessive menstrual bleeding in premenopausal women by destroying or removing the endometrial lining while conserving the uterus. There is a group of women who will benefit from this typically 1-day outpatient procedure and avoid hysterectomy. However, this procedure seems to be used in addition to rather than instead of hysterectomy for benign uterine conditions such as abnormal uterine bleeding, according to a study by researchers at the Agency for Healthcare Research and Quality.
Cynthia M. Farquhar, M.D., Sandra Naoom, B.Psych., and Claudia A. Steiner, M.D., M.P.H., accessed data on women with benign uterine conditions who underwent either hysterectomy or endometrial ablation using the State Inpatient and Ambulatory Surgery Databases of the Healthcare Cost and Utilization Project for six States from 1990 to 1997. In the six States studied, endometrial ablation was used as an additive medical technology rather than as a substitute for hysterectomy.
The proportionate increases in endometrial ablation did not mirror proportionate decreases in hysterectomy in any of the six States studied. Hysterectomy rates either declined slightly or remained unchanged. Yet, the rate for endometrial ablation for women with benign uterine conditions for all States increased significantly. The analysis included women who may have had more than one procedure, with hysterectomies perhaps following failed ablations. The researchers suggest implementing strategies to reduce hysterectomy rates in favor of endometrial ablation as well as other nonsurgical interventions tried in other countries.
See "The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States," by Drs. T wenty-nine percent of the U.S. population and one out of every three children is a member of an ethnic or racial minority group. By 2025, almost 40 percent of Americans and about half of all U.S. children with be minorities. Thus, emergency room (ER) clinicians will often encounter children needing emergency care who come from families with cultural differences or who don't speak English at all or only haltingly.
Failure to appreciate the importance of culture and language in pediatric emergencies can be catastrophic. It can lead to problems in obtaining informed consent, inadequate understanding of diagnoses and treatment by families, unnecessary medical and social service evaluations, inadequate analgesia, and dissatisfaction with care, warn the authors of a study supported in part by the Agency for Healthcare Research and Quality (HS11305).
Glenn Flores, M.D., of Boston Medical Center, and his colleagues reviewed studies on culture and language in the emergency care of children that were published in English or Spanish from 1966 to 1999. A final database of 117 articles yielded numerous insights. For instance, parents and children with limited English proficiency often don't get the interpreters they need and have a poor understanding of their diagnosis and treatment. Also, certain ethnicspecific beliefs such as the Navajo hozhooji (the belief that negative thoughts and words can cause harm) can impede informed consent (for example, to surgery that a doctor acknowledges to have some risks).
Numerous folk illnesses, such as empacho among Latinos (term for chronic indigestion in children with diarrhea), can affect care because symptoms often overlap with potentially serious biomedical conditions such as intestinal blockage or appendicitis. The first clinical contact may be with folk healers, and certain folk remedies are harmful or even fatal (for example, use of lead powders for empacho). Use of cultural Researchers assess optimal timing of surgery following one or more attacks of uncomplicated diverticulitis I n-hospital deaths from five major conditions declined once Cleveland hospitals and physicians began to publicly report in-hospital deaths from those conditions. However, deaths within 30 days of hospital discharge declined for only two of the conditions and increased significantly for another, according to a study supported by the Agency for Healthcare Research and Quality (HS09969). Using in-hospital mortality rates to monitor trends in outcomes for hospitalized patients may lead to misleading conclusions, according to David W. Baker, M.D., M.P.H., of Case Western Reserve University.
Dr. Baker and his colleagues examined mortality trends from 1991-1997 for Medicare patients hospitalized with acute myocardial infarction (AMI, heart attack), congestive heart failure (CHF), gastrointestinal hemorrhage (GIH), chronic obstructive pulmonary disease (COPD), pneumonia, or stroke during the Cleveland Health Quality Choice program. This program shared information on hospitals' mortality rates and length of stay (adjusted for level of patient risk) with coalition members (businesses, hospitals, and physicians) and published it in two data reports per year.
During the study period, risk-adjusted in-hospital mortality declined significantly for all conditions except stroke and GIH, with absolute declines ranging from -2.1 percent for COPD to -4.8 percent for pneumonia. However, mortality rates in the early postdischarge period rose significantly for all conditions except COPD, with increases ranging from 1.4 percent for GIH to 3.8 percent for stroke. As a result, 30-day mortality was fairly flat, and for stroke, the risk-adjusted 30-day mortality rate actually increased by 4.3 percent. The researchers conclude that use of published hospital report cards for hospital profiling remains an unproven strategy for improving outcomes of care for medical conditions.
See "Mortality trends during a program that publicly reported hospital performance," by Dr. Outcomes/Effectiveness Research B y the late 1990s, breast cancer mortality rates began to decline for the first time in several decades. However, rates failed to decline for older women (age 65 or older), and mortality rates actually increased for older black women. Two studies supported by the Agency for Healthcare Research and Quality (HS08395) and led by Jeanne S. Mandelblatt, M.D., M.P.H., of Georgetown University School of Medicine, recently examined age and race differences in the treatment of breast cancer.
The first study found that older black women are less likely than older white women with localized breast cancer to receive breast conserving surgery (BCS) plus radiation, currently the preferred treatment over mastectomy (complete breast removal). The second study shows that women with localized breast cancer who are older, not functioning as well at the time of surgery, and whose surgeons are cancer specialists are less likely to undergo lymph node biopsy after BCS. Older black women are less likely than older white women to receive recommended treatment for local breast cancer, according to this study. The researchers analyzed data from 984 black and 849 white Medicare-insured women 67 years of age or older diagnosed with local breast cancer in 1994 and a subset of 732 surviving women who were interviewed 3 to 4 years after treatment. The researchers used these data to calculate odds of treatment, adjusting for age, other coexisting medical problems, attitudes, geographic region, and area measures of socioeconomic status (SES) and health care resources. Overall, 67 percent of women underwent mastectomy and 33 percent received BCS.
Radiation was omitted in one-third of women after BCS.
Black women were older, sicker, diagnosed with stage 2 cancer (vs. stage 1) more often, and lived in areas where the elderly were more impoverished than their white counterparts. Elderly black women were 36 percent more likely than elderly white women to receive mastectomy versus BCS and radiation, even after taking into account poverty and other factors. Also, when they did receive BCS, black women were 48 percent more likely than white women to not have radiotherapy, a practice that would increase their risk of local cancer recurrence, although the absolute number of women affected was small.
The odds of mastectomy were nearly eight times as high and the odds of not having radiation after BCS were over five times as high for women living in areas with the highest quartile of elderly residents living below the poverty level Researchers examine age and race differences in treatment of breast cancer continued on page 13
Uncomplicated diverticulitis
continued from page 11 (resolve with conservative treatment such as antibiotics, bed rest, and intravenous fluids) in a hypothetical group of 60-year-old men and women. They estimated costs from Medicare reimbursement rates and estimated a 5-year recurrence rate of 26 percent based on previous studies.
Surgery following a second attack of diverticulitis did not increase life expectancy or qualityadjusted life years (QALYs), but it did increase costs considerably. On average, waiting until after the third attack cost $2,500, yielding 14 years of life expectancy and 14 QALYs, which was far more costsaving than the other two options. Only when the yearly risk of having an outpatient recurrence was 42 percent did prophylactic surgery after the first attack exceed option three in terms of life expectancy and QALYs. However, the incremental cost per QALY saved was $4,500,000. The model results did not change until the 5-year risk for the third attack equaled 61 percent. Only at this point, was option 2 (surgery following the second attack) the preferred strategy at a cost of $95,000 per additional QALY saved.
More Surgical biopsy (dissection) of axillary lymph nodes (in the arm pit) is almost always done during mastectomy to rule out lymph node involvement for women with breast cancer. Lymph node biopsy after BCS requires an additional incision and general anesthesia compared with often-used local anesthesia for BCS. Women with local breast cancer who are older, not functioning as well at the time of surgery, and whose surgeons are cancer specialists are less likely to undergo axillary lymph node biopsy after BCS, according to this study.
The investigators examined patient, clinical, and surgeon characteristics associated with the non-use of axillary lymph node biopsy after BCS. They used medical record and survey data for 464 elderly women with stage 1-2 breast cancer who underwent BCS at hospitals in four U.S. regions, as well as survey data from their 158 surgeons.
Most (63 percent) women underwent axillary lymph node biopsy after BCS. Increasing age was strongly associated with decreasing odds of undergoing node biopsy, even after considering other factors. Independent of age and other factors, women in the lowest quartile of physical functioning were 37 percent less likely to undergo node dissection compared with women in the highest quartile. Women who were cared for by surgeons with subspecialty training in surgical oncology were 60 percent less likely to undergo node dissection than women who were cared for by other surgeons (52 vs. 87 percent). Other provider and institutional factors, including geographic location, were not significant.
Although axillary lymph node biopsy after BCS is a reasonable procedure, its omission may represent appropriate management since the procedure can cause substantial problems. For instance, other research has shown that onethird of women who undergo axillary dissection experience longterm burning or prickling sensations, limited range of motion, and permanent lymphedema (puffiness or swelling of the arms), which can interfere with tasks such as self-care, shopping, and cleaning. Recently introduced sentinel lymph node biopsy causes fewer problems than complete dissection. Nevertheless, until more data are available, physicians must help women balance the risks and potential benefits of axillary lymph node dissection in making treatment decisions, suggest the researchers. ■
Infantile hypertrophic pyloric stenosis continued from page 13
A previous study by the same researchers (see October 2002 Research Activities, page 3) found an increased risk of IHPS among infants who received erythromycin before 2 weeks of age. The current study found no association with prenatal erythromycin prescriptions and IHPS either after 32 weeks' gestation or at any time during pregnancy. There was an association between maternal prescriptions for nonerythromycin macrolides and IHPS, but the evidence was limited by the small number of affected children. Also, more mothers taking these antibiotics were black and urban and had sexually transmitted diseases which, along with other unmeasured factors, may have affected development of IHPS, note the researchers.
More The Task Force, an independent panel of experts sponsored by the Agency for Healthcare Research and Quality, reviewed studies on the effect of screening for prostate cancer using prostate-specific antigen (PSA) tests and digital rectal exams to prevent death in men over the age of 40. The Task Force found that although the tests are effective for detecting disease, there is insufficient evidence that they improve long-term health outcomes.
Over their lifetime, 15 percent of U.S. men eventually will be diagnosed with prostate cancer, and three-fourths of these men will be diagnosed after age 65. A man in the United States has a 3 percent chance of dying from prostate cancer. Because prostate cancer usually grows slowly, many men diagnosed with the diseaser will die of other causes, especially men who are older than 65 when they are diagnosed.
If clinicians opt to perform prostate cancer screening for individual patients, the Task Force recommends that they first discuss the uncertain benefits and possible harms. Benefits of the tests may include early detection of cancer, but harms may include false-positive results and unnecessary anxiety, biopsies, and potential complications of treating some early cancers that may never have affected a patient's health or well being. Potential side effects of surgery and radiation treatment include erectile dysfunction, urinary incontinence, and bowel dysfunction.
One part of a National Cancer Institute randomized clinical trial of over 150,000 people-the Prostate, Colorectal, Lung, and Ovarian Screening Trial-is looking at whether screening men with digital rectal examinations plus a PSA test can reduce deaths from prostate cancer. Results from this large trial, which should be available later this decade, could help clarify the benefits of prostate cancer screening.
The Task Force, the leading independent panel of private-sector experts in prevention and primary care, conducts rigorous, impartial assessments of all the scientific evidence for a broad range of preventive services. Its recommendations are considered the gold standard for clinical preventive services.
The Task Force grades the strength of the evidence from "A" (strongly recommends) to "D" (recommends against) or "I" (insufficient evidence). The Task Force found insufficient evidence that clinicians should routinely provide prostate cancer screening to those men not at high risk for the disease. In 1996, the Task Force recommended against routine prostate cancer screening for men.
Go to www.ahrq.gov/clinic/3rduspstf/prostatescr/ to access the prostate cancer screening recommendation and materials for clinicians. Previous Task Force recommendations, summaries of the evidence, easy-toread fact sheets explaining the recommendations, and related materials are available from AHRQ. See the back cover of Research Activities for ordering information.* Clinical information is also available from the National Guideline Clearinghouse™ at www.guideline.gov. ■ Task force finds evidence lacking on whether routine screening for prostate cancer improves health outcomes valuation and treatment of patients with suspected cervical spine injury (CSI), often due to blunt trauma, usually involves radiologic imaging. Plain xrays of the spine usually are the first step in screening such injuries, but they may miss from 20 to 40 percent of cervical spine fractures. Therefore, computed tomography (CT) or magnetic resonance imaging (MRI) are often used as well.
Three studies supported by the Agency for Healthcare Research and Quality (HS08239) and led by William R. Mower, M.D., Ph.D., of the University of California, Los Angeles School of Medicine, recently examined the use of imaging to diagnose CSI. The first study concluded that MRI is not as reliable as CT for excluding CSIs but is better than CT for identifying soft tissue injuries. The second study found that spinal cord injuries among blunt trauma victims that are not revealed on plain back x-rays are rare and occur predominantly among adults. The third study revealed that geriatric victims of blunt trauma are more likely to suffer CSI than younger victims, and that five clinical criteria can save some of them from unnecessary spinal imaging. All three studies are described here. Although CT has been the radiographic study of choice after obtaining plain x-rays in CSI patients, some centers have begun using MRI more frequently. However, MRI is not reliable for excluding cervical spine injuries, and fractures in particular, according to this multicenter study. The researchers examined the overall clinical performance of CT and MRI (following simple x-ray of the cervical spine) of CSI patients seen at university-and community-based facilities, trauma and nontrauma centers, and in teaching and nonteaching environments. Overall, 688 patients with 1,302 separate CSIs were enrolled. Following plain cervical spine x-rays, two-thirds of these patients underwent CT and one-fifth had MRI, with few patients having both.
CT Researchers assess the performance of radiographic imaging of spinal injuries continued on page 16 C ommunity radiologists give widely different interpretations of the same mammogram, according to a study supported by the Agency for Healthcare Research and Quality (HS10591). In fact, younger, more recently trained radiologists had two to four times more false-positive readings (diagnosing possible cancer when there was none) than older radiologists. This finding from a real-world community setting bolsters similar evidence from earlier studies on radiologists' variability using test sets of mammograms.
In the current study, Joann G. Elmore, M.D., M.P.H., of the University of Washington School of Medicine, and her colleagues examined results from 24 community radiologists' interpretations of 8,734 screening mammograms from 2,169 women over an 8-1/2 year period. They found wide variation in how frequently different radiologists noted masses, calcifications, and other suspicious lesions. For instance, one radiologist did not observe any calcifications, while another radiologist noted calcifications in more than 20 percent of the films read.
The radiologists also varied widely in their diagnostic interpretations and recommendations for additional screens and biopsies. The rate of falsepositive readings among the radiologists ranged from 2.6 percent to 15.9 percent. However, after adjustment for differences in patient, radiologist, and testing characteristics, the range of false-positive rates narrowed to 3.5 to 7.9 percent.
Women who were younger, were premenopausal, were using hormone replacement therapy at the time of the mammogram, had a family history of breast cancer, or had a previous biopsy were more likely to have a false-positive result. Also, more women who
Community radiologists vary widely in how they interpret the same screening mammograms Spinal injuries
continued from page 15 percent), and spinal cord edema or contusion (93 percent). Central cord syndrome was described in 10 cases.
The researchers conclude that SCIWORA is an uncommon injury pattern in general, occurring in only 0.08 percent of all patients enrolled. Pediatric cases of SCIWORA were conspicuously absent in this large series. The central cord syndrome was prospectively identified in one-third of SCIWORA patients. The NEXUS criteria for patients at low risk of CSI (had none of the following: altered level of alertness, intoxication, posterior midline cervical spine tenderness, distracting painful injury, or focal neurologic deficit) were highly sensitive in identifying that these high-risk patients required imaging. Elderly patients who suffer from blunt cervical trauma are more likely than younger patients to have cervical spine injury (CSI), perhaps due to osteopenia (reduced bone mass), physical disability, or other age-related conditions. Also, they are more likely to suffer CSI from minor falls. However, use of certain clinical criteria can help avoid unnecessary cervical spine imaging in this group, according to this study. The investigators analyzed the use of five clinical criteria (NEXUS decision instrument) to identify risk of CSI among 2,943 elderly blunt trauma victims (8.6 percent of the entire NEXUS sample of blunt trauma patients treated at 21 U.S. medical centers).
NEXUS defined as "low-risk" patients exhibiting none of the following five criteria: altered level of alertness, intoxication, posterior midline cervical spine tenderness, distracting painful injury, and focal neurologic deficit. The rate of CSI was twice as great among geriatric as nongeriatric patients (4.6 vs. 2.2 percent). Odontoid fractures (in the upper spine) were particularly common in geriatric patients, accounting for 20 percent of geriatric fractures compared with 5 percent of nongeriatric fractures.
NEXUS criteria classified 14 percent of geriatric patients and 12.5 percent of non-geriatric patients as low risk for CSI. CSI occurred in only two low-risk geriatric patients, and these patients' injuries met the definition of a clinically insignificant injury. Therefore, the sensitivity of the NEXUS decision instrument for clinically significant injury in the geriatric group was 100 percent. These findings suggest that use of the NEXUS criteria can substantially reduce unnecessary imaging among geriatric victims of blunt trauma. ■ T he annual mortality rate for patients with end-stage renal disease (ESRD) is 20 percent, with a 5-year survival rate of about 29 percent for patients undergoing renal dialysis. The highest risk of dying occurs during the first year of renal dialysis. Although early nephrologist evaluation is associated with better patient outcomes, 25 percent of ESRD patients first see a nephrologist only a month before beginning dialysis.
ESRD patients who consult with a nephrologist more than 3 months before beginning dialysis, and who see that specialist more often, are less likely to die during the first year of dialysis, according to a study supported in part by the Agency for Healthcare Research and Quality (HS09398 In the study, which was supported by the Agency for Healthcare Research and Quality (HS07755), Dr. Morgenstern and his colleagues randomized 672 patients in a managed care organization with low back pain (with or without leg pain) that had begun more than a year prior to the study, to receive either medical or chiropractic care.
Chiropractic patients reported receiving more self-care advice than did medical patients; they were more likely to receive an explanation of their treatment; and they visited their primary providers more often. The mean care satisfaction score (on a 10-50 scale, from least to most satisfied) after 4 weeks of followup for chiropractic patients was 5.5 points higher than the score for medical patients (36.1 vs. 30.6). Clinical improvement during the first 2 weeks of followup, more and longer visits to the provider, and initial confidence with the assigned treatment were associated with greater satisfaction at 4 weeks.
Receipt of self-care advice and explanation of treatment had strong estimated effects on patient satisfaction in this study. The difference in mean satisfaction scores between chiropractic and medical patients nearly disappeared (to 0.1) for patients who received an explanation of their treatment and at least four items of self-care advice (for example, advice on diet, weight loss, stress reduction, or specific ways to manage back pain such as moist heat or a back brace). These findings are consistent with previous studies that demonstrate associations between the amount of information patients receive and their degree of satisfaction, concludes Dr. In this largest study to date of predialysis patients, the researchers identified all patients in the New Jersey Medicaid and Medicare programs who began maintenance dialysis during a 6-year period and had been diagnosed with renal disease more than 1 year prior to dialysis. They documented use of nephrologist services during the year prior to the start of dialysis, along with other clinical and sociodemographic variables and mortality during the first year of dialysis.
Patients who did not see a nephrologist until 90 days or less before they began dialysis (late referral) were 37 percent more likely to die in the first year of dialysis than patients referred to a nephrologist earlier. Similarly, those who visited a nephrologist fewer than five times in the year prior to dialysis were 15 percent more likely to die in the first year of dialysis compared with those who had five or more visits. Socioeconomic status did not appear to affect timing of nephrologist referral, since Medicaid and Medicare patients had no greater risk of death than more affluent patients, after adjusting for other factors.
However, use of nephrologists may correlate with other issues of access and quality of care, which themselves may play an important role in outcomes. For example, patients who are referred to a nephrologist may have a primary care physician who is also more conscientious about managing other aspects of their care, such as hypertension or nutrition. Alternatively, patients referred to nephrologists are more likely to be treated with erythropoietin for anemia, possibly lowering the risk of death, or to have a permanent vascular access created for maintenance dialysis, especially a primary fistula (opening surgically created from one's own skin). This, in turn, may reduce the risk of infections during renal replacement therapy and/or improve dialysis doses. The investigators suggest that these findings be confirmed in younger and less indigent patients. The later a patient with ESRD is evaluated by a nephrologist, the greater the risk of death, especially for black patients and those who have diabetes, conclude these researchers. They prospectively studied 828 patients with newonset ESRD treated at 81 dialysis facilities throughout the United States and calculated time from first evaluation by a nephrologist to initiation of dialysis. They classified evaluations done less than 4 months prior to dialysis as late, 4 to 12 months prior to dialysis as intermediate, and over 12 months as early. They examined rate of death from initiation of dialysis to an average of 2.2 years later.
After adjustment for potential confounding factors, late evaluation was more common among black men than white men (45 vs. 25 percent), uninsured patients than insured patients (57 vs. 29 percent), and patients with severe rather than mild coexisting disease (35 vs. 23 percent). Compared with patients who were evaluated early, the risk for death was 30 percent and 80 percent greater, respectively, among patients with intermediate or late evaluation, after adjustment for dialysis method, demographic characteristics, and socioeconomic status. After further adjustment for factors such as the presence and severity of coexisting medical problems, patients with intermediate or late referral still had a higher risk of dying than patients referred early.
Late referral could be due to asymptomatic renal failure in ESRD, noncompliance with referrals, lack of access to any medical care, or attitudes of primary care doctors about referral of ESRD patients to specialists. Clinicians need a system to remind them to refer patients to nephrologists when they are at an early stage of chronic renal failure, especially black men, the uninsured, and patients with severe coexisting illness. New practice guidelines for the treatment of chronic kidney disease define at what glomerular filtration rate (an indicator of kidney functioning) a patient should be referred to a nephrologist. ■ I n a recent study, depressed patients who reported greater satisfaction with care at 18 months were more likely to receive higher quality care at 24 months. However, the reverse was not true. Higher quality of care at 18 months did not predict higher satisfaction at 24 months, according to the study, which was supported in part by the Agency for Healthcare Research and Quality (HS08349). These findings persisted, even after controlling for patient case mix, recent use of mental health care services, and stability of the doctor-patient relationship.
It may be that satisfied patients receive better technical care 6 months later because they tend to take a more active role in their care and are therefore more likely to stay on medications, show up for therapy, or both. These patients may also feel more confidence and trust in their doctors and, as a result, may be more comfortable disclosing their symptoms and relating their experiences. This gives the doctor more opportunity to deliver good quality care, explain Maria Orlando, Ph.D., and Lisa S. Meredith, Ph.D., of RAND.
The researchers examined the impact of two measures of interpersonal quality of care-care satisfaction and the patient-provider relationship (PPR)-on technical quality of care for depression at 18 and 24 months among 697 adults enrolled in the Partners in Care study. Technical quality of care for depression was evaluated based on appropriate antidepressant medication for at least 2 of the past 6 months or at least eight sessions of depression counseling from a mental health specialist during the past year. Patients who reported having the same doctor as they did 6 months previously tended to rate both satisfaction with care and the PPR higher than those with a different doctor.
More details are in "Understanding the causal relationship between patientreported interpersonal and technical quality of care for depression," by Drs. Orlando and Meredith, in Medical Care 40(8), pp. 696-704, 2002 . ■ Patient satisfaction seems to lead to higher quality of care for depression Primary Care I nfluenza and pneumonia together are the fifth leading cause of death among the U.S. elderly. Even with appropriate treatment, 30 to 40 percent of deaths among the elderly are due to pneumonia. Yet in 1999, only 67 percent of older people received flu shots, and only 54 percent received the one-time pneumococcal vaccine. Rates were even lower for older blacks and Hispanics. Most unvaccinated elderly adults don't know that they need the pneumonia vaccine and feel that they are not at risk for getting the flu, according to a study supported by the Agency for Healthcare Research and Quality (HS09874).
Educational campaigns to increase vaccination rates among the elderly should emphasize the risk and severity of these diseases for older people, vaccine safety, and the existence of a pneumococcal vaccine, suggests Richard K. Zimmerman, M.D., M.P.H., and Tammy A. Santibanez, Ph.D., of the University of Pittsburgh. In 2000, Drs. Zimmerman, Santibanez, and colleagues surveyed a broad spectrum of elderly patients at urban, rural, and suburban sites about their vaccination status and beliefs about vaccination.
Overall, 1,007 people were surveyed. Those who received flu shots were much more likely than those who did not to know the symptoms of the flu. Similarly, 41 percent of elderly people who had been vaccinated against pneumonia could describe at least one classic symptom of the disease, compared with 35 percent of those who had not been vaccinated. Those who thought they could do something to keep from contracting pneumonia were more likely to have been vaccinated against it than those who thought they could not prevent it (77 vs. 54 percent). Of those who did not get flu shots, 19 percent felt they were not likely to contract the Many elderly people believe they are unlikely to get the flu and don't realize they need the pneumonia vaccine continued on page 20 P atients with chronic kidney disease (CKD) do not have adequate preventive health care screenings prior to beginning renal dialysis. Screening becomes even less adequate after starting dialysis (renal replacement therapy), even though dialysis requires regular and frequent contact with health care professionals. As patients approach and undergo dialysis, the health care they receive revolves predominantly around preparation for and delivery of the dialysis (for example, prevention of anemia), and preventive health care may fall through the cracks.
To avoid this and improve the health of these vulnerable patients, the relationship between the nephrologist (or dialysis facility) and the primary care A ll men and women aged 50 years and older should be screened for colon cancer, which is the third most common form of cancer in the United States. Yet only about half of primary care patients are screened either with fecal occult blood testing (FOBT, to detect blood in stool) or colon examination by sigmoidoscopy/colonoscopy, concludes a study supported in part by the Agency for Healthcare Research and Quality (HS07373). Researchers from the MEDTEP Research Center at the University of California, San Francisco, retrospectively reviewed the medical records from three primary care practices in an academic medical center to identify colon cancer screening among patients of all races aged 50 to 74 who had at least one visit between mid-1995 and mid-1997.
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They defined screening most liberally as FOBT in the past 1 to 2 years, sigmoidoscopy in the previous 5 to 10 years, or colonoscopy in the past 10 years. Of the 6,039 patients who made medical visits during the study period, only 53 percent had undergone some type of colon cancer screening. About 47 percent had received FOBT in the past 2 years, about one-quarter had undergone sigmoidoscopy in either the past 5 or 10 years, and only 3 percent had undergone colonoscopy. Only 14 percent of patients had received FOBT in the past year as well as sigmoidoscopy in the past 5 years (as recommended in most current guidelines).
Women were less likely to be screened than men, and patients who were younger (aged 50 to 54), had been seen less frequently, were uninsured, or did not have managed care insurance were less likely to be screened than others. Patients who had been diagnosed with a gastrointestinal illness or had a family history of colon cancer were more likely to have been screened. However, only a third of high-risk patients with a family history of the disease had undergone any cancer screening. Patients of nurse practitioners were 22 percent less likely to receive FOBT than patients seen by physicians, and patients of residents were 21 percent less likely than those of faculty to have sigmoidoscopy.
More details are in "Colon cancer screening in the ambulatory setting," by Judith M. Walsh, M.D., M.P.H., Samuel F. Posner, Ph.D., and Eliseo J. Perez-Stable, M.D., in Preventive Medicine 35, pp. 209-218, 2002 Research and Quality (HS09398) . They examined the use of five preventive care screenings from 1990 to 1996 among 3,014 New Jersey Medicaid and Medicare patients with CKD at 1 year before and after beginning dialysis. The screening tests included mammography, Pap smears, prostate cancer screening, diabetic eye exams (since many long-term diabetics develop CKD), and glycosylated hemoglobin testing (to measure blood sugar levels among diabetics).
With the exception of diabetic eye exams, 40 percent or fewer patients received recommended preventive care screening. The mammography screening rate for women aged 52 to 69 years was 27 percent before dialysis and 26 percent during the first year of dialysis. For women aged 21 to 64 years, cervical cancer screening was 17 percent the year before dialysis and 21 percent during the first year of dialysis. Prostate cancer screening, diabetic eye exams, and glycosylated hemoglobin testing were performed less often after onset of dialysis compared with the year before (27 vs. 40 percent, 76 vs 81 percent, and 11 vs. 19 percent, respectively This study used data from the Multicenter AIDS Cohort Study (MACS), which contains interview and medical record data from 1984 through 1994, to determine the relationship between a history of preventable opportunistic infection (POI) and chronic mortality (death more than 30 days after acute infection). The researchers controlled for HIV-1 RNA, absolute CD4 cell counts, use of antiretroviral therapy, and age. The study sample consisted of 2,193 homosexual adult men from four U.S. cities who were HIV-infected but asymptomatic. They were followed for nearly 8 years. People with a history of POI (for example, Pneumocystis carinii pneumonia) were over 28 times more likely to die 30 days or more after the acute infection compared with those without such a history (mortality rate of 66.7 vs. 2.3 per 100 personyears).
After adjustment for CD4 count and maximum HIV viral load, people with a history of POI still had a risk of death that was seven times as high as those without such a history. CD4 count was also an independent risk factor for chronic mortality. In the absence of a history of POI, those with CD4 cell counts less than 50 had a risk of death that was nearly nine times as high as it was for those with CD4 counts higher than 200. Maximum HIV viral load had no independent effect on chronic mortality, but unlike CD4 counts, viral load was not measured every 6 months.
Older men had a 34 percent higher risk of death within 30 days, whereas the risk of death was 63 percent lower for those who used antiretroviral therapy. These results support the idea that HIV may cause mortality through a number of different pathways. HIV viral load, CD4 count, and HAART have different effects on health-related quality of life (HRQL) among patients with HIV disease, finds this study. The investigators analyzed the independent effect of each of these three factors on HRQL for 513 HIV-infected people in four domains of HRQL: physical functioning (PF, ranging from rigorous activities like running to carrying groceries, and walking a block); role function (RF, whether health kept them from working at a job, going to school, or doing work around the house in the prior 4 weeks); energy level (EL, fatigue that kept them from doing things they wanted, for example); and health perceptions (HP) after adjustment for other factors affecting HRQL.
The mean age of study participants was 40 years, 26 percent were female, 38 percent were minority, 57 percent were gay or bisexual, 33 percent had used injectable drugs, and 44 percent were using HAART. Mean HRQL scores ranged from 55.5 for EL to 75.5 for RF out of 100 points. Compared with patients with CD4 counts over 500, patients with CD4 counts less than 200 had lower PF (-8.8 points), RF (-9.3 points), and HP (-7.8 points). Patients with detectable HIV loads had lower PF scores (-7.7 Nearly all (95 percent) of the 614 doctors who responded to the survey agreed that a bioterrorist attack was a real threat within the United States. However, only 24 percent believed they could recognize signs and symptoms of a bioterrorismrelated illness in their patients, and 38 percent rated their current knowledge of the diagnosis and management of bioterrorism-related illness as poor. Only 27 percent of doctors surveyed believed that the U.S. health care system could respond effectively to such an attack, and just 17 percent thought that their local hospitals and medical communities could respond effectively. About half (56 percent) knew how to get information if they suspected an attack in their community, which is the greatest predictor of being able to diagnose and report cases.
See prior anthrax cases, they assumed that 25 percent of symptomatic cases in each scenario would be critically ill on arrival to the distribution center, another 25 percent would be moderately ill, and the remaining 50 percent only mildly ill.
The researchers also assumed that 10 percent of the noninfected population would either be "worried well" or have nonbioterrorism-related illness warranting onsite evaluation. For the purposes of this model, they did not consider other critical logistical components of response plans such as drug re-supply, crowd control, or criminal investigation activity taking place inside the distribution center, important parts of the public health response to the 2001 anthrax attacks. Their research was supported in part by the Agency for Healthcare Research and Quality (contract 290-00-0013).
See "Modeling the public health response to bioterrorism: Using discrete event simulation to design antibiotic distribution centers," by Dr. Hupert, Alvin I. Mushlin, M.D., Sc.M., and Mark A. Callahan, M.D., in the September/October 2002 Medical Decision Making 22(Suppl.), pp. S17-S25. ■ T he health care community must take action along several fronts to become better prepared for biological terrorism from anthrax, smallpox, and other agents. Over time, the United States will move away from a HAZMAT/first responder model of bioterrorism to an emergency department/hospital provider model. There will be less emphasis on decontamination and more emphasis on diagnosis, according to Jessica Jones, M.D., of the University of Alabama at Birmingham.
In a recent article, Dr. Jones and her colleagues at UAB, The Southern Research Institute, and the U.S. Army Medical Research Institute of Infectious Diseases describe our current state of readiness for biological terrorism, as well as some of the challenges that lie ahead. Their work was supported by the Agency for Healthcare Research and Quality (contract 290-00-0022).
For instance, surveillance will be improved with development of nationally computerized databases such as LEADERS (Lightweight Epidemiological Advanced Detection Emergency Response System). LEADERS collects data via the Internet or a faxed sheet listing the types of syndromes seen in U.S. emergency departments (EDs). Results are compiled every 12 hours and distributed to ED workers and public health authorities who generate alerts when unusual patterns appear.
Handheld, lightweight, fully automated devices that can detect biological agents in the environment in less than half an hour are now in the final stages of development. However, the technical difficulty of environmental detection of biological agents makes early clinical recognition more effective at present. That will require savvy laboratory workers and clinicians, who are trained to recognize laboratory or clinical indications of bioterrorism-related illness.
A national Laboratory Response Network is being developed by the Centers for Disease Control and Prevention to provide reagents and training, along with a system of rapid regional laboratory referral of suspicious specimens. Various medical groups are developing programs to train physicians and emergency medical personnel for bioterrorism crises.
Also being studied are new classes of broad spectrum antibiotics to treat bioterrorism-related illness and ways to diagnose such infections before symptoms develop. For example, gene "chips" are being developed that might make it possible to conduct a broad range of diagnostic tests from a single blood sample. In 1999, $51 million was appropriated by Congress to the Department of Health and Human Services to develop vaccine and drug stockpiles. Experts identify the challenges facing the health care community in becoming better prepared for biological terrorism O ne little-studied form of managed care is providersponsored managed care organizations (PSOs). They can be fully owned and operated by hospital health maintenance organizations (HMOs), vertically integrated networks of both physicians and hospitals, or by a physician-only network. PSOs are thought to improve hospital finances by decreasing patient management and utilization costs. PSOs may also be able to restore the public's trust in managed care by responding to community health needs, depending on the makeup of the hospital board.
The likelihood of a hospital owning any form of managed care organization (MCO) increases with the number of community leaders and health professionals on its board. The number of business leaders on the board had no impact on the likelihood of such arrangements, according to a study supported by the Agency for Healthcare Research and Quality (HS08610).
Community leaders on the board are concerned primarily with ensuring accessible and high-quality care in the community. They place a lower priority on the financial effect of their decisions as long as the hospital remains solvent. Health professionals on hospital boards most likely are favorably inclined toward involvement with PSOs because they provide a more flexible working environment for health professionals than insurance-based MCOs. PSOs also allow local health professionals to benefit financially from any increased revenues resulting from improved hospital operations.
Hospital managers should consider their hospital board's composition and the interests of the populations they represent before actively pursuing a strategic action, suggests the study's lead author, Shadi S. Saleh, Ph.D., of the State University of New York at Albany. Dr. Saleh and colleagues examined the effect of the composition of rural hospital governing boards on hospitals' involvement in provider-sponsored MCOs by examining responses to a 1997 survey sent to chief executive officers of 140 rural hospitals in Iowa and Nebraska.
See "The effect of governing board composition on rural hospitals' involvement in provider-sponsored managed care organizations," by Dr. etween 1980 and 1990 , during the fee-for-service (FFS) insurance era, physician fees rose 110 percent. One strategy that managed care organizations (MCOs) use to reduce the rate of growth in physician fees is selective contracting with a network of providers who agree to lower their prices in order to gain access to the potential revenue of people insured by the MCO. In turn, the MCOs provide their beneficiaries with financial incentives, such as decreased copayments, if they use network providers. This competitive pressure prompted physicians to reduce the fees they negotiated with MCOs during the 1990-1992 period, according to a study supported by the Agency for Healthcare Research and Quality (HS07068).
Although managed care was successful in providing some market discipline to physician pricing at the time, today several States require MCOs to include "any willing provider" in their provider network. This is likely to undermine the threat of network exclusion and associated loss of patients raised by selective contracting, notes study author, Jack Zwanziger, Ph.D., of the University of Illinois at Chicago. He analyzed several national data sets, including a survey of MCO fee schedules, to determine the impact of several market factors on negotiated physician fees during the 1990-1992 period.
The surveyed MCOs from diverse geographic areas did not abolish the historical pattern of physician fees, but they did modify relative fees to align them more closely with their relative resource use. The most influential factors in fee negotiations were physician supply and the proportion of the area's population enrolled in managed care plans. The larger the MCO presence in the area, the lower the physician fees were. Also, fees were lower in areas with more physicians per capita. The number of physicians in a plan's local provider network had almost no effect on fees.
More details are in "Physician fees and managed care plans," by Dr. Provider-sponsored managed care organizations work best when community leaders and health professionals are involved
